Delivery Order SPE2DB20D2104-SPE2DB23FT42L
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,422.60 firm fixed-price contract is for the delivery of LOW-OGESTREL-28 TABLET 28S, a generic pharmaceutical product. The award has an ultimate completion date of September 5, 2024. AmerisourceBergen holds a larger, $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,413.36 firm fixed-price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,176.59, is a Firm Fixed Price Delivery Order for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2024 and was awarded on January 22, 2024. This contract award is associated with a larger Indefinite Delivery...
- This is a $3,170.50 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of LOW-OGESTREL-28 TABLET 28S, a prescription contraceptive medication. The award has a completion date of September 25, 2024 and does not utilize a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,879.76 firm fixed-price delivery order contract is for the supply of the medication LOW-OGESTREL-28 TABLET 28S. The contract has an ultimate completion date of June 15, 2023 and was awarded on June 14, 2023. This contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,053.84 firm fixed-price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product, with a completion date of July 15, 2024. The award is not designated as a set-aside contract. It is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distribution company. The contract is for the supply of LOW-OGESTREL-28 TABLET 28S, a prescription medication, to support military healthcare requirements. The award has a ceiling value of $1,766.50 and a completion date of September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,171.30 firm fixed-price delivery order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a contraceptive medication. The contract has an ultimate completion date of January 13, 2025 and was awarded on January 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB24FQ2V4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,217.10 firm fixed-price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of September 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, registered in the System for Award...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $5,600.20 firm fixed-price contract is for the supply of LOW-OGESTREL-28 TABLET 28S, a prescription medication, with a completion date of May 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT42LDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,382.80 firm fixed-price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a generic contraceptive medication. The contract has an ultimate completion date of May 9, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that broader IDC. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 5/8/23 |